BioNTech falls on outlook, departure of co-founders
Source: SeekingAlpha
2026-03-10 07:48:05 ET
BioNTech ( BNTX ), the partner of Pfizer ( PFE ) for the Comirnaty COVID-19 vaccine, fell 18% in the premarket on Tuesday after its Q4 2025 financials, as its full-year outlook fell short of Street forecasts. ...
Read the full article on Seeking Alpha
For further details see:
BioNTech falls on outlook, departure of co-founders
Pfizer Inc.
NASDAQ: PFE
PFE Trading
-0.48% G/L:
$26.765 Last:
14,932,304 Volume:
$27.02 Open:
PFE Latest News
PFE Stock Data
$156,612,814,520
5,628,850,476
0.02%
1712
N/A
Pharmaceuticals
Healthcare
US
New York
